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Candida species have been implicated in a variety of 
human diseases. Candida albicans is the most prevalent 
species isolated from yeast bloodstream infections and 
is associated with high rates of morbidity and mortal-
ity (Wey et al. 1988, Gudlaugsson et al. 2003). The risk 
factors for developing candidaemia include prematurity, 
azotaemia, central venous catheter use, chemotherapy, 
mucous membrane barrier breakage, broad spectrum 
antibiotics, neutropaenia, total parenteral nutrition, ste-
roids and surgery. Specific patient groups vulnerable 
to candidaemia include critically ill intensive care unit 
(ICU) patients, neonates and patients with haematologi-
cal or solid malignancies (Colombo & Guimarães 2003, 
Almirante et al. 2005, Eggimann et al. 2005, Colombo et 
al. 2006, Otrosky-Zeichner et al. 2011).
Candida spp colonisation is an independent risk factor 
for candidaemia, but it is well established that a minority of 
colonised patients will acquire invasive diseases. Despite 
the fact that 3-60% of patients may be colonised by Candi-
da spp during hospitalisation, less than 5% of them will de-
velop candidaemia (Pittet et al. 1994, Cornwell et al. 1995, 
Borzotta & Beardsley 1999, Godoy et al. 2003, Marchetti et 
al. 2004, Leon et al. 2006). 
Previous authors have suggested that the risk of 
candidaemia increases with the number of body sites 
colonised by Candida. The intensity of Candida colo-
nisation in critically ill patients may predict subsequent 
infections with identical strains (Pittet et al. 1994, Vin-
cent et al. 1998). Recently, Leon et al. (2006) developed 
a scoring system named the “Candida score” and proved 
that patients with Candida multifocal colonisation had 
higher overall mortality rates compared to those patients 
with unifocal colonisation by this yeast. The calculation 
of a Candida score was based on the variables generated 
from a logistic regression model that evaluated the risk 
factors independently associated with candidaemia. The 
authors rounded the score for patients with exposure to 
total parenteral nutrition, surgery or multifocal Candida 
species colonisation up to 1 and the weight for clinically 
severe sepsis up to 2 and established a cut-off value of 
2.5. Therefore, critically ill patients with candidaemia 
who had a score of 2.5 were considered to be 7.75 times 
more likely to have a proven infection than patients with 
a Candida score up to 2.5.
It is clear that the number of body sites colonised by 
the Candida species impacts the risk of acquiring can-
didaemia; however, whether the persistence or replace-
ment of a single clone of C. albicans in multiple anatomi-
cal sites of the organism may represent an additional risk 
in the transition from commensal to invasive candidiasis 
has not been largely investigated. 
By evaluating the genotypes of 165 C. albicans iso-
lates using multilocus sequence typing (MLST) and ABC 
genotyping, Odds et al. (2006) have shown that in cases 
of candidaemia, strain maintenance, predominant clon-
ality and microvariation occur in isolates obtained from 
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Candida albicans is a common member of the human microbiota and may cause invasive disease in susceptible 
populations. Several risk factors have been proposed for candidaemia acquisition. Previous Candida multifocal col-
onisation among hospitalised patients may be crucial for the successful establishment of candidaemia. Nevertheless, 
it is still not clear whether the persistence or replacement of a single clone of C. albicans in multiple anatomical sites 
of the organism may represent an additional risk for candidaemia acquisition. Therefore, we prospectively evaluated 
the dynamics of the colonising strains of C. albicans for two groups of seven critically ill patients: group I included 
patients colonised by C. albicans in multiple sites who did not develop candidaemia and group II included patients 
who were colonised and who developed candidaemia. ABC and microsatellite genotyping of 51 strains of C. albicans 
revealed that patients who did not develop candidaemia were multiply colonised by at least two ABC genotypes of 
C. albicans, whereas candidaemic patients had highly related microsatellites and the same ABC genotype in colonis-
ing and bloodstream isolates that were probably present in different body sites before the onset of candidaemia. 
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non-sterile sites cultured before the onset of Candida 
bloodstream infection. These results strongly suggest that 
candidaemic patients are usually infected with their own 
commensal isolates that exhibit multiple colonisation and 
clonal dissemination as previously described (Reagan et 
al. 1990, Pittet et al. 1991, 1994, Caugant & Sandven 1993, 
Voss et al. 1994, Marr et al. 2001, Verma et al. 2003).
In contrast, few authors have suggested that multi-
ple strain types may coexist in the same clinical sample 
from a unique patient (Takasuka et al. 1998, Kam & 
Xu 2002, Samaranayake et al. 2003). By investigating 
different C. albicans colonies obtained from healthy 
volunteers and patients with oral and vaginal candidi-
asis, Jacobsen et al. (2008) reported a higher prevalence 
of strain microevolution and substitution among healthy 
volunteers compared to infected patients. The authors 
inferred that superficial infection may result from the 
selective overgrowth of a single subtype or fewer sub-
types before invasive infection.
By comparing the concordance among MLST and 
ABC genotyping, Odds et al. (2006) stated that the lat-
est technique is reliable when strains differ in more than 
one single nucleotide polymorphism. However, ABC 
genotyping should not be used as a unique method for C. 
albicans typing. First described in 1999 by McCullough 
et al., ABC genotyping was developed on the basis of the 
presence or absence of an insert in the DNA that encodes 
for the 25S ribosomal RNA gene among different C. albi-
cans genotypes (McCullough et al. 1999). Microsatellite 
typing using primer M13, which amplifies short tandem 
repeats, was first employed to type Cryptococcus strains 
in Brazil (Casali et al. 2003) and has been extensively 
used to type this encapsulated yeast (Loperena-Alvar-
ez et al. 2010, Pedroso et al. 2010, Ferreira-Paim 2011). 
Nevertheless, only a few studies have employed the M13 
primer to type C. albicans (Bartie et al. 2001).
It seems reasonable to hypothesise that the prolifera-
tion of a single C. albicans subtype may be a predictor 
for candidaemia. However, there is a lack of prospective 
studies in the medical literature that have determined 
whether the dissemination of a single clone of C. albi-
cans to multiple anatomical sites occurs in patients who 
remain colonised by this yeast, but do not develop can-
didaemia during hospitalisation. In this study, we pro-
spectively evaluated the dynamics of the persistence or 
replacement of C. albicans genotypes for two well estab-
lished groups of critically ill patients: group I included 
three patients colonised by C. albicans in multiple sites 
who did not develop candidaemia during hospitalisation 
and group II included four patients who were colonised 
by C. albicans and who developed candidaemia.
SUBJECTS, MATERIALS AND METHODS
Strains - We selected a total of 51 isolates of C. albi-
cans that were prospectively collected from the different 
anatomical sites of six patients admitted at a tertiary care 
hospital in São Paulo, Brazil. In addition, we included a 
patient (patient 5) who had two positive urine cultures for 
C. albicans collected at a seven-day interval and who de-
veloped candidaemia. These isolates were obtained from 
patients sequentially admitted to the ICU who agreed to 
participate in a surveillance confidential study. Only pa-
tients who required more than 72 h of ICU admission 
were enrolled in this study. Samples were systematically 
collected from urine, rectal swabs, skin surrounding the 
catheter entry site, surgery wounds, tracheal secretions 
and blood until the onset of candidaemia or discharge 
from the ICU (Table). The clinical isolates were collect-
ed during the study over a period of two years. The iso-
lates was stored on YPD glycerol (10 g/L yeast extract, 
20 g/L peptone, 20 g/L dextrose and 3% glycerol) at 
-70ºC. The C. albicans strains ATCC90028 and SC5314 
were used as external control strains for the phenotypic 
and molecular identification and typing of our isolates.
Procedures for species identification - The isolates 
were plated on CHROMagar Candida® (CHROMagar 
Microbiology, Paris, France) to check for purity, viabil-
ity and screening for green colonies. The production of 
chlamydoconidia on cornmeal agar and green colour on 
CHROMagar Candida® were the presumptive tests ad-
opted for the initial identification of C. albicans. The 
final identification of the strains was confirmed by the 
sequencing of the ribosomal DNA (rDNA) internal tran-
scribed spacer (ITS) region (White et al. 1990). 
C. albicans genotyping methods - To establish the 
genetic relatedness of the colonising and bloodstream 
isolates of C. albicans, all of the strains were typed by 
microsatellite and ABC genotyping (based on the ampli-
fication of an intron present in the 26S rDNA gene).
DNA extraction - The isolates were grown in Falcon 
tubes that contained 2 mL YPD medium for 16 h at 30ºC 
at 200 rpm in a gyratory shaker for 48 h. DNA was ex-
tracted using the fast small scale isolation protocol pre-
viously described (Melo et al. 1998).
Polymerase chain reaction (PCR) assay and 
ITS region sequencing - The primers ITS1 (5′-
TCCGTAGGTGAACCTGCGG-3′) and ITS4 (5′-
TCCTCCGCTTATTGATAT-3′) were used to amplify the 
ITS region (White et al. 1990). The samples were ampli-
fied in a Thermocycler (model 9600) (Applied Biosys-
tems, Foster City, CA, USA) using the following cycling 
parameters: one initial cycle of 94ºC for 3 min followed 
by 30 cycles of 1 min at 94ºC, 1 min at 57ºC, 1 min at 72ºC 
and a final cycle of 5 min at 72ºC. The PCR products were 
size-separated by agarose gel electrophoresis and the 
gel was stained in a 0.5 µg/mL ethidium bromide buf-
fer solution (1 x tris-acetate-ethylenediamine tetraacetic 
acid). The purified PCR products were sequenced using 
the dideoxynucleotide method in an ABI PRISM 3100 
automated sequencer (Applied Biosystems, CA, USA). 
The sequencing reaction included each primer sepa-
rately and the BigDyeTM Terminator reagent kit (Ap-
plied Biosystems) and it was performed according to the 
manufacturer’s instructions. The nucleotide sequences 
were submitted for BLAST analysis (blastn) at the Na-
tional Center for Biotechnology Information (ncbi.nlm.
nih.gov) website for species identification. 
Microsatellite typing PCR and ABC genotyping 
PCR - Microsatellite typing was performed using the 
primer M13 (5’-GAGGGTGGCGGTTCT--3’) (IDT) as 
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previously described (Casali et al. 2003). ABC geno-
typing was performed with the following primers: CA-
INT-L (5′-ATAAGGGAAGTCGGCAAAATAGATCC- 
GTAA-3′) and CA-INT-R (5′-CCTTGGCTGTGGT- 
TTCGCTAGATAGTAGAT-3′) (McCullough et al. 1999). 
Briefly, 1.0 µL of DNA 40 ng/µL, 2.5 µL of 10 x PCR 
buffer (100 mM tris-HCl, pH 8.3, 500 mM KCl, 3.5 mM 
MgCl2), 5 µL of dNTPmix (100 mM each dNTP), 1.0 µL 
of each primer (50 pmol/µL), 0.13 µL of Tween 20 and 
1.0 unit of Taq DNA polymerase were added to a final 
volume of 25 µL. Forty-five cycles of amplification were 
performed using the same cycling parameters described 
previously, except the annealing temperature was 36ºC 
for the microsatellite typing.
Computer-assisted microsatellite data analysis - Gel 
images were analysed with the GelCompar II software, 
version 4.5 and BioNumerics (Applied Maths, Kortrijk, 
Belgium). The similarities between the profiles were cal-
culated using the Dice coefficient to generate the matrixes 
of similarity coefficients to dendrogram constructions. For 
profile clustering, the unweighted pair-group method with 
arithmetic averages was used with a tolerance of 2%.
RESULTS
All of the isolates that were phenotypically identified 
as C. albicans had their identification confirmed with 
rDNA ITS region sequencing. Notably, the patients in-
cluded in this analysis were not on antifungal therapy or 
prophylaxis at the time of enrolment. Patient demograph-
ic data and underlying conditions are described in Table.
The genomic DNA of all of the isolates was suc-
cessfully amplified with the M13 primer, which targets 
genome repetitive sequences. The DNA amplification 
generated well-defined band patterns, ranging from 
500 pb-2 KB and the microsatellite technique showed 
sufficient discriminatory power for recognising in-
traspecific variation (Figure). As expected, the external 
control strains of C. albicans, SC5314 and ATCC90028, 
were placed in completely different clusters by the den-
drogram analysis performed using GelCompar II, prov-
ing the efficiency of the technique in separating strains 
isolated from different geographic areas (Figure).
C. albicans microsatellite typing results of colonised 
vs. candidaemic patients - The results obtained using 
microsatellite typing suggest that each patient was colo-
nised by a group of specific strains. Isolates with some 
degree of genetic variability were obtained from group 
I patients (who did not develop candidaemia). This find-
ing suggests that these isolates underwent microevolu-
tion or were completely replaced during the patient’s 
hospitalisation. The majority of the genotypic profiles 
of the sequential isolates from patient 1 were identical 
(100% similarity). Isolates 904 C1 (catheter tip), 904 A 
(rectal swab) and 904 B (urine) were placed within dif-
ferent clusters. Patient 2 was colonised in three different 
body sites. Strains 143 A (rectal swab) and 143 C (sur-
gery wound) showed 100% similarity, whereas an iso-
late from tracheal secretion (138 C) had a very different 
genotypic profile compared to the two other strains and 
was placed in a different cluster after the dendrogram 
analysis (84% similarity). This trend was still more re-
markable among the isolates from patient 3. Some of the 
isolates presented only 60% similarity and were placed 
in very distinct clusters, except for two strains that were 
considered identical (170 A and 184 A1 both from rectal 
swabs collected on different days) (Figure).
Regarding the patients who were colonised by C. 
albicans and who developed candidaemia (group II), 
bloodstream isolates were indistinguishable or highly 
related to other strains of the same patient, although 
some degree of genetic variability was observed among 
previously colonising strains. Patient 4 had colonising 
strains that exhibited genetic variability ranging from 
85-100% similarity, suggesting that strain microevolu-
tion occurred during the patient’s ICU hospitalisation. 
Furthermore, isolate 731 D from blood was considered 
indistinguishable from isolate 704 B (100% similarity), 
a strain recovered from urine before the onset of candi-
daemia. Patient 5 was included in the analysis because 
of two positive urine cultures that were collected within 
a week of developing candidaemia. These strains (19 B 
and 15 B1) were considered highly related (above 97% 
similarity) to the 15 D bloodstream isolate. Patient 6 
showed some degree of difference among the colonis-
ing strains of C. albicans (86-100% similarity), possibly 
due to microvariations and similarity of 93% among a 
C. albicans bloodstream isolate (757) and the previous 
colonising strains. Finally, patient 7 had a blood isolate 
(997, 5 G) that was 100% similar to the colonising iso-
lates of different body sites, such as urine (1002 B) and 
surgery wounds (982 E) and 97% similarity among all of 
the isolates, proving that the strains were highly related.
C. albicans ABC genotyping results of colonised 
vs. candidaemic patients - When ABC genotyping was 
used, we observed that at least two different A, B or C 
genotypes were observed within the colonising strains of 
C. albicans from group I (patients who did not develop 
candidaemia). Nevertheless, patients who were colonised 
and developed candidaemia (group II) due to C. albicans 
had a single A or B genotype strain at the beginning of 
colonisation through the onset of candidaemia (Table).
Regarding group I, patient 1 was colonised by sev-
eral genotype C strains, but a genotype A strain was also 
isolated. This isolate (904 C1; skin surrounding the cath-
eter entry site) was placed in a different cluster from the 
majority of the isolates from the same patient when the 
microsatellite technique was used. Patient 2 had two gen-
otype B strains that were also considered to be indistin-
guishable (143 A, rectal swab; 143 C, surgery wound) and 
a genotype C strain (138 C; tracheal secretion) that was 
again placed in a different cluster when the microsatellite 
method was used. Interestingly, patient 3 was colonised 
by a combination of A and B genotypes (Table).
In contrast, group II patients were solely colonised 
by a single A or B genotype of C. albicans in all ana-
tomical sites. Patients 4 and 7 were only colonised by 
genotype A strains, whereas patients 5 and 6 were only 
colonised by genotype B strains (Table). None of the 
strains isolated from the candidaemic patients belonged 
to the C genotype.
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DISCUSSION
In this study, we prospectively evaluated the geno-
types of the colonising and infecting strains of C. albi-
cans from patients sequentially admitted for more than 72 
h in the ICU. Overall, we found a great diversity among 
the different colonising strains of C. albicans obtained 
from various anatomical sites of patients who did not de-
velop candidaemia despite previous multifocal colonisa-
tion, whereas the persistence of a single A or B genotype 
was documented in patients who developed candidaemia. 
These data support the hypothesis that the presence of a 
single, well-adapted dominant strain in non-sterile sites 
obtained from patients with candidaemia may increase 
the risk of transition from commensalism to infection.
It is important to emphasise that the patients who did 
not develop candidaemia were colonised by different 
C. albicans genotypes and strain replacement (as sup-
ported by 2 different techniques) occurred even among 
Candida strains isolated from the same anatomical site 
at two different time points of collection. Patient 3 was 
sequentially colonised by a combination of genotype A 
and B strains within the same anatomical site. Accord-
ing to Jacobsen et al. (2008), a combination of different 
genotypes is expected more among colonised individu-
als compared to patients exhibiting superficial infec-
tions with C. albicans. Therefore, it is reasonable to 
hypothesise that an adapted genotype succeeded during 
disease development, whereas strain replacement may 
have occurred in patients who did not develop candidae-
mia during hospitalisation.
It is very unlikely that commensal strain replacement 
occurs in patients who develop candidaemia (Reagan et 
al. 1990, Pittet et al. 1991, 1994, Caugant & Sandven 
1993, Voss et al. 1994, Marr et al. 2001, Verma et al. 
2003, Odds 2010). By evaluating 30 hospitalised patients 
with multifocal colonisation by C. albicans who devel-
oped candidaemia, Marco et al. (1999) found highly 
similar or identical genetic patterns between colonising 
and infecting strains typed with a Ca3 probe. Odds et al. 
(2006) demonstrated a high genetic relatedness within 
the colonising strains from multiple sites and the blood-
stream isolates obtained from 11 different sets of strains 
of a patient admitted to the ICU.
Several authors have demonstrated that candidaemic 
patients are previously colonised in multiple non-sterile 
sites by Candida strains of clonal origin; however, we 
did not find any prospective study that evaluated wheth-
er this phenomenon occurs in critically ill patients with 
multifocal colonisation who do not develop candidae-
mia. Our findings suggest that C. albicans strain re-
placement may occur in colonised patients who do not 
progress to candidaemia.
Despite being a controversial issue, several authors 
have recommended serial fungal surveillance cultures in 
critically ill patients to better identify individuals who 
should be treated with empirical antifungal therapy when 
a substantial degree of fungal colonisation is observed 
(Eggimann et al. 2005, Leon et al. 2006). According to 
our data, ABC genotyping could help clinicians predict 
whether or not a critically ill patient who is multicolo-
nised by C. albicans would develop candidaemia. 
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In conclusion, as demonstrated by ABC and microsat-
ellite genotyping, we suggest that in addition to the number 
of body sites colonised by Candida, multifocal colonisation 
by a single genotype may increase the risk of developing 
candidaemia in colonised patients. We demonstrated that 
a patient who was colonised in a single anatomical site by 
a persistent C. albicans genotype B (isolated from urine) 
progressed to invasive infection (patient 5). The limita-
tions of our study are represented by the small number of 
patients evaluated in the present series and by the fact that 
strain virulence factors were not included in our analysis. 
Further studies are necessary to confirm whether our find-
ings may be extrapolated to larger populations.
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